A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab Versus Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting
Principal investigator: Heini Lassus
Trial site: HUS Comprehensive Cancer Center
Link to the ClinicalTrials.gov website
